Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CNS Pharmaceuticals, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
01/16/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline"
01/16/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals, Inc. Investor Presentation – January 2020"
01/13/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals, Inc. Investor Presentation – January 2020"
11/22/2019 8-K Quarterly results
11/13/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy